Cargando…

The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer

OBJECTIVE: This study aimed to investigate the relationship between prognostic and tumor parameters of cervical cancer patients, such as tumor size (TS), tumor volume (TV), and tumor volume reduction rate (TVRR) after external beam radiotherapy. METHODS: A total of 217 patients with advanced cervica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chang, Wang, Shubin, Ye, Wenjing, Wang, RanLin, Tan, Mingyu, Zhang, Hanyi, Zhou, Jie, Li, Minglun, Wei, Lichun, Xu, Peng, Zhu, Guiquan, Lang, Jinyi, Lu, Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329537/ https://www.ncbi.nlm.nih.gov/pubmed/35912169 http://dx.doi.org/10.3389/fonc.2022.934110

Ejemplares similares

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
por: Zhang, Cui-Dai, et al.
Publicado: (2021)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

The predictive value of tumor volume reduction ratio on three-dimensional endorectal ultrasound for tumor response to chemoradiotherapy for locally advanced rectal cancer
por: Chen, Limei, et al.
Publicado: (2022)

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
por: Unterrainer, Marcus, et al.
Publicado: (2021)

Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)
por: Yabuki, Kenichiro, et al.
Publicado: (2015)

The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
por: Koo, Tae Ryool, et al.
Publicado: (2014)

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
por: Taugner, Julian, et al.
Publicado: (2021)

Survival with concurrent temozolomide and radiotherapy in pediatric brainstem glioma with relation to the tumor volume
por: Taran, Shachi Jain, et al.
Publicado: (2015)

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Chen, Nai-Bin, et al.
Publicado: (2020)

Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer
por: Zhang, Jingjing, et al.
Publicado: (2021)

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Feng, Mei, et al.
Publicado: (2013)

Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy
por: Pehlivan, Umur Anil, et al.
Publicado: (2023)

Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy
por: Wang, Rong, et al.
Publicado: (2022)

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer
por: Zhang, Ying, et al.
Publicado: (2013)

Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2022)

Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal Carcinoma
por: Huang, Ruihong, et al.
Publicado: (2020)

Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy
por: Moon, Seung Hwan, et al.
Publicado: (2015)

Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy
por: Li, Nan, et al.
Publicado: (2017)

High Mean Corpuscular Volume as a Predictor of Poor Overall Survival in Patients with Esophageal Cancer Receiving Concurrent Chemoradiotherapy
por: Li, Ke-jie, et al.
Publicado: (2020)

“Sandwich Therapy”—Immunotherapy Plus Concurrent Chemoradiotherapy for Advanced Esophagogastric Junction Carcinoma: Report of Two Cases and Literature Review
por: Wu, Lei, et al.
Publicado: (2022)

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Lee, Tae Hoon, et al.
Publicado: (2022)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study
por: Lyu, Jiahua, et al.
Publicado: (2018)

Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors
por: Lu, W, et al.
Publicado: (2015)

γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma
por: Li, Ling, et al.
Publicado: (2018)

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor
por: Zhao, Jingjing, et al.
Publicado: (2020)

A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC)
por: Choi, See Min, et al.
Publicado: (2015)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
por: Katsui, Kuniaki, et al.
Publicado: (2020)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Prognostic influence of 3-dimensional tumor volume on breast cancer compared to conventional 1-dimensional tumor size
por: Hwang, Ki-Tae, et al.
Publicado: (2018)

Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors
por: Bazyar, Soha, et al.
Publicado: (2016)

Prognosticating Gross Tumor Volume in Head-and-Neck Cancer – Redefining Gross Tumor Volume Beyond Contouring
por: Ahmed, Imtiaz, et al.
Publicado: (2023)

Consequences of tumor planning target volume reduction in treatment of T2-T4 laryngeal cancer
por: Vugts, Cornelia AJM, et al.
Publicado: (2014)

Tumor regression patterns by follow-up duration in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
por: Kong, Moonkyoo, et al.
Publicado: (2017)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers
por: Zhang, Tian-Wei, et al.
Publicado: (2023)

The Predictive Value of Tumor Volume and Its Change on Short-Term Outcome for Esophageal Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
por: Liang, Shuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kfu1m45lksaht27mhsfocc2jm